Business
Wellbeing Digital Sciences Welcomes Najla Guthrie as Chief Executive Officer
Wellbeing Digital Sciences Welcomes Najla Guthrie as Chief Executive Officer.
About this update from Wellbeing Digital Sciences Inc.
[{"type":"text","content":"\n VANCOUVER, British Columbia, April 04, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based healthcare company focused on innovative clinical solutions, artificial intelligence-powered digital therapeutics and contract research, and its Board of Directors are pleased to welcome Najla Guthrie as its new Chief Executive Officer (“CEO”) effective March 31, 2022. Ms. Guthrie has been appointed to lead the development of an evolved competitive strategy through a refreshed mission and vision for the Company. The previously announced accomplishments by Wellbeing’s wholly owned subsidiaries, KGK Science Inc. (“KGK”) and IRP Health (“IRP”), have positioned it well for Ms. Guthrie’s tenure as Wellbeing’s new leader. Ms. Guthrie has been the President and CEO of KGK since 1997 and most recently also held the title of Chief Science Officer for Wellbeing. Over the years, Najla has grown KGK into a leading North American contract research organization that provides high-quality clinical research trials with a focus on the nutraceutical, cannabis, and emerging psychedelic industries. Ms. Guthrie has been instrumental in publishing over 50 papers in peer-reviewed journals and has given numerous presentations at both the national and international levels. Najla is aptly fitted for her new role as CEO of Wellbeing and is highly regarded in the research, science, and leadership communities. As a summary of the Company’s recent achievements, KGK was selected by Lophos Pharmaceuticals Inc. for a novel study to evaluate a path to market for sustainably grown peyote-derived natural health products. Wellbeing has also commenced its single arm, open label study of patients with post-traumatic stress disorder who are undergoing the proprietary physical therapy program at IRP clinics. IRP has also recently had its innovative Reactivation therapy program formally approved by Veterans Affairs Canada as an interdisciplinary clinic outpatient program at three locations, which sets Wellbeing up for continued success on the path to expanding its treatment of veterans and first responders across Canada. Lastly, the inpatient Ketamine Integrated Therapy Experience program in associati...